GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cardiff Oncology Inc (STU:XE7C) » Definitions » Purchase Of Investment

Cardiff Oncology (STU:XE7C) Purchase Of Investment : €-31.30 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Cardiff Oncology Purchase Of Investment?

Cardiff Oncology's purchase of investment for the three months ended in Mar. 2024 was €-0.85 Mil. It means Cardiff Oncology spent €0.85 Mil on purchasing investments. Cardiff Oncology's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2024 was €-31.30 Mil.

Compared with last quarter (€-2.38 Mil in Dec. 2023 ), Cardiff Oncology spent less money on purchasing investments in Mar. 2024 (€-0.85 Mil).

Cardiff Oncology Purchase Of Investment Historical Data

The historical data trend for Cardiff Oncology's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardiff Oncology Purchase Of Investment Chart

Cardiff Oncology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -154.33 -86.12 -64.27

Cardiff Oncology Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -34.86 -12.50 -15.58 -2.38 -0.85

Cardiff Oncology Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-31.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cardiff Oncology Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Cardiff Oncology's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Cardiff Oncology (STU:XE7C) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cardiff Oncology Inc (STU:XE7C) » Definitions » Purchase Of Investment
Comparable Companies
SABS IMUX SRNEQ OCUP KZR ANEB HRGN AVRO NKGN INAB OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XKRX:068270 BNTX ALNY
Traded in Other Exchanges
CRDF:USA XE7C:Germany
Address
11055 Flintkote Avenue, San Diego, CA, USA, 92121
Website
https://www.cardiffoncology.com
Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.

Cardiff Oncology (STU:XE7C) Headlines

No Headlines